epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Cardene SR
    nicardipine
  • remove Hecoria
    tacrolimus
  • remove Kerlone
    betaxolol
  • remove Oxaydo
    oxycodone

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Cardene SR (nicardipine) + Oxaydo (oxycodone)

Avoid/Use Alternative


nicardipine + oxycodone

use alternative or monitor respiratory rate, BP; consider decr. oxycodone dose: combo may incr. oxycodone levels, risk of CNS and respiratory depression, psychomotor impairment, severe hypotension (including orthostasis, syncope), other adverse effects (hepatic metabolism inhibited, additive effects)

Monitor/Modify Tx

Smiley face Smiley face Cardene SR (nicardipine) + Hecoria (tacrolimus)

Monitor/Modify Tx


nicardipine + tacrolimus

monitor tacrolimus levels, ECG, BP, renal fxn: combo may incr. tacrolimus levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)

Smiley face Smiley face Hecoria (tacrolimus) + Kerlone (betaxolol)

Monitor/Modify Tx


tacrolimus + betaxolol

monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Smiley face Smiley face Kerlone (betaxolol) + Oxaydo (oxycodone)

Monitor/Modify Tx


betaxolol + oxycodone

monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

Additional Considerations

Smiley face Smiley face tacrolimus in Hecoria

monitor tacrolimus levels in combo with HCV Direct Acting Antiviral (DAA) tx; viral eradication may improve hepatic metabolic function, alter tacrolimus levels, efficacy

avoid combo with beverages or products containing ethanol and tacrolimus extended-release (ER) formulations; combo may incr. tacrolimus release rate, levels, risk of adverse effects, decr. duration of efficacy

Smiley face Smiley face oxycodone in Oxaydo

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information